Gossamer Bio Inc. (GOSS)
GOSS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.76
+5.17% on the day
Market cap
$59.7M
Micro cap
Revenue · 2025
$48.5M
-57.7% on 2024
Net income · 2025
-$170.4M
-351.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | GOSS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001728117 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $48.5M |
| Net income | -$170.4M |
| Operating income | -$170.7M |
| Net margin | -351.5% |
| Operating margin | -352.2% |
| Revenue growth | -57.7% |
| Cash | $37.7M |
| Total assets | $172.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-03-17 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEF 14A | 2026-09-16 |
Source: SEC EDGAR submissions feed, 482 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| PLRX | Pliant Therapeutics Inc. | $0.9680 | -1.83% | $59.9M |
| XLO | Xilio Therapeutics Inc. | $9.22 | +1.60% | $60.7M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| CNTB | Connect Biopharma Holdings Limited | $0.9188 | +1.45% | $57.9M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| BOLD | Boundless Bio Inc. | $2.43 | -4.71% | $56.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier